These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19584260)

  • 1. Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
    Karpel-Massler G; Schmidt U; Unterberg A; Halatsch ME
    Mol Cancer Res; 2009 Jul; 7(7):1000-12. PubMed ID: 19584260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.
    Halatsch ME; Schmidt U; Behnke-Mursch J; Unterberg A; Wirtz CR
    Cancer Treat Rev; 2006 Apr; 32(2):74-89. PubMed ID: 16488082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of EGFR in malignant gliomas.
    Ye F; Gao Q; Cai MJ
    Expert Opin Ther Targets; 2010 Mar; 14(3):303-16. PubMed ID: 20148717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
    Brandes AA; Franceschi E; Tosoni A; Hegi ME; Stupp R
    Clin Cancer Res; 2008 Feb; 14(4):957-60. PubMed ID: 18281526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.
    Chakravarti A; Dicker A; Mehta M
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):927-31. PubMed ID: 14967452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug combinations enhancing the antineoplastic effects of erlotinib in high-grade glioma.
    Karpel-Massler G; Wirtz CR; Halatsch ME
    Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):384-94. PubMed ID: 21612575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.
    Nieder C; Grosu AL; Mehta MP; Andratschke N; Molls M
    Expert Rev Neurother; 2004 Jul; 4(4):691-703. PubMed ID: 15853588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
    Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.
    Viana-Pereira M; Lopes JM; Little S; Milanezi F; Basto D; Pardal F; Jones C; Reis RM
    Anticancer Res; 2008; 28(2A):913-20. PubMed ID: 18507036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
    Sonabend AM; Dana K; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising new therapies for malignant gliomas.
    Fine HA
    Cancer J; 2007; 13(6):349-54. PubMed ID: 18032970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts.
    Gadji M; Crous AM; Fortin D; Krcek J; Torchia M; Mai S; Drouin R; Klonisch T
    Eur J Pharmacol; 2009 Dec; 625(1-3):23-30. PubMed ID: 19836372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors.
    Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY
    Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for molecularly targeted therapy against epidermal growth factor receptor ligands.
    Miyamoto S; Fukami T; Yagi H; Kuroki M; Yotsumoto F
    Anticancer Res; 2009 Mar; 29(3):823-30. PubMed ID: 19414315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum.
    Pérez-Soler R; Delord JP; Halpern A; Kelly K; Krueger J; Sureda BM; von Pawel J; Temel J; Siena S; Soulières D; Saltz L; Leyden J
    Oncologist; 2005 May; 10(5):345-56. PubMed ID: 15851793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: Growth factor and Ras signaling pathways.
    Newton HB
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):595-614. PubMed ID: 14599084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibitors in children with malignant gliomas.
    Herrington B; Kieran MW
    Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas.
    Doherty L; Gigas DC; Kesari S; Drappatz J; Kim R; Zimmerman J; Ostrowsky L; Wen PY
    Neurology; 2006 Jul; 67(1):156-8. PubMed ID: 16832099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
    Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
    Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.